Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma - PubMed (original) (raw)
Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma
P Brouckaert et al. J Exp Med. 1989.
Abstract
Plasma samples obtained from patients receiving a 24-h continuous infusion of human recombinant (hr)TNF or a combination of two overlapping, 24-h continuous infusions of hrIFN-gamma and hrTNF were analyzed for IL-6 in a sensitive bioassay. A transient appearance of circulating IL-6 was observed with peak levels between 3 and 6 h after the start of the hrTNF infusion. These peak levels correlated quite well with the dose of hrTNF administered (r = 0.86; p less than 0.001). The maximal value observed was 27.5 ng/ml IL-6 in a sample of a patient receiving 545 micrograms/m2 hrTNF. The combination of hrIFN-gamma (200 micrograms/m2) and hrTNF in the infusions resulted in higher IL-6 levels than a comparable dose of hrTNF alone. A maximal value of 23.5 ng/ml IL-6 was observed in a patient receiving 205 micrograms/m2 hrTNF. No IL-6 was found in the plasma of patients during the 12-h infusion with hrIFN-gamma alone, except for two borderline samples.
Similar articles
- A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivo.
Demetri GD, Spriggs DR, Sherman ML, Arthur KA, Imamura K, Kufe DW. Demetri GD, et al. J Clin Oncol. 1989 Oct;7(10):1545-53. doi: 10.1200/JCO.1989.7.10.1545. J Clin Oncol. 1989. PMID: 2506316 - Characteristics of fever and acute-phase response induced in rabbits by IL-1 and TNF.
Morimoto A, Sakata Y, Watanabe T, Murakami N. Morimoto A, et al. Am J Physiol. 1989 Jan;256(1 Pt 2):R35-41. doi: 10.1152/ajpregu.1989.256.1.R35. Am J Physiol. 1989. PMID: 2492162 - Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans.
Lantz M, Malik S, Slevin ML, Olsson I. Lantz M, et al. Cytokine. 1990 Nov;2(6):402-6. doi: 10.1016/1043-4666(90)90048-x. Cytokine. 1990. PMID: 2129506 - Cytokines modulate interleukin-6 production by human salivary gland cell line.
Katz J, Nagler R, Barak S, Livneh A, Baum B, Atkinson J, Shemer J. Katz J, et al. Cell Immunol. 1994 Dec;159(2):211-9. doi: 10.1006/cimm.1994.1308. Cell Immunol. 1994. PMID: 7994755 - Therapeutic properties of biological response modifiers. A discussion of preclinical and clinical studies.
Talmadge JE. Talmadge JE. Contrib Gynecol Obstet. 1989;17:49-62. Contrib Gynecol Obstet. 1989. PMID: 2495895 Review. No abstract available.
Cited by
- Induction of inflammatory cell infiltration and necrosis in normal mouse skin by the combined treatment of tumor necrosis factor and lithium chloride.
Beyaert R, De Potter C, Vanhaesebroeck B, Van Roy F, Fiers W. Beyaert R, et al. Am J Pathol. 1991 Mar;138(3):727-39. Am J Pathol. 1991. PMID: 1848044 Free PMC article. - Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice.
Nakane A, Numata A, Minagawa T. Nakane A, et al. Infect Immun. 1992 Feb;60(2):523-8. doi: 10.1128/iai.60.2.523-528.1992. Infect Immun. 1992. PMID: 1730485 Free PMC article. - The decrease in nonsplenic interleukin-6 (IL-6) production after splenectomy indicates the existence of a positive feedback loop of IL-6 production during endotoxemia in dogs.
Moeniralam HS, Bemelman WA, Endert E, Koopmans R, Sauerwein HP, Romijn JA. Moeniralam HS, et al. Infect Immun. 1997 Jun;65(6):2299-305. doi: 10.1128/iai.65.6.2299-2305.1997. Infect Immun. 1997. PMID: 9169767 Free PMC article. - Differential regulation of cytokine and cytokine receptor mRNA expression upon infection of bone marrow-derived macrophages with Listeria monocytogenes.
Demuth A, Goebel W, Beuscher HU, Kuhn M. Demuth A, et al. Infect Immun. 1996 Sep;64(9):3475-83. doi: 10.1128/iai.64.9.3475-3483.1996. Infect Immun. 1996. PMID: 8751887 Free PMC article. - Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.
Montgomery SL, Mastrangelo MA, Habib D, Narrow WC, Knowlden SA, Wright TW, Bowers WJ. Montgomery SL, et al. Am J Pathol. 2011 Oct;179(4):2053-70. doi: 10.1016/j.ajpath.2011.07.001. Epub 2011 Aug 9. Am J Pathol. 2011. PMID: 21835156 Free PMC article.
References
- J Immunol Methods. 1984 Mar 16;67(2):379-88 - PubMed
- Int J Cancer. 1986 Nov 15;38(5):763-9 - PubMed
- Proc Natl Acad Sci U S A. 1986 Dec;83(24):9679-83 - PubMed
- J Infect Dis. 1988 Mar;157(3):413-20 - PubMed
- Immunol Today. 1988 May;9(5):137-9 - PubMed